血清素释放试验阳性而PF4依赖性酶免疫分析阴性:是HIT还是不是HIT?
该研究调查了血清素释放试验阳性但PF4依赖性酶免疫分析阴性的HIT频率。索引病例显示假阴性IgG特异性EIA导致肝素再暴露并引发严重反应,但6年内8546例中约0.2%呈此血清学特征,复核15例均为分类错误或SRA假阳性,无确诊SRA+/EIA- HIT病例。结论认为该情形极罕见,EIA阳性要求是减少假阳性SRA报告的有效质量控制措施。
要点
- SRA阳性/EIA阴性的HIT极罕见,6年8546例中仅约0.2%呈此特征且复核无确诊。
- 索引病例证实假阴性IgG特异性EIA可致肝素再暴露并引发近致命性过敏样反应。
- 要求EIA阳性作为SRA检测的质量控制可降低假阳性SRA报告风险。
核心结论
- SRA阳性/EIA阴性的HIT虽可能存在(如索引病例),但临床情形极为罕见。
- 要求EIA阳性是减少假阳性SRA报告的有效质量控制措施。
研究设计与样本
- 研究包括索引病例报告及6年期间参考实验室HIT检测患者的实验室与临床特征回顾。
- 参考实验室同时使用SRA和IgG特异性EIA检测HIT,共纳入8546例患者。
主要发现
- 索引病例中五种不同IgG特异性免疫分析主要呈阴性或弱阳性,而SRA强阳性(肝素、PF4或PF4/肝素条件下),且可被Fc受体阻断单克隆抗体抑制。
- 8546例患者中约0.2%呈SRA+/EIA- profile,复核15例均提示文书/实验室分类错误或SRA假阳性,未发现SRA+/EIA- HIT病例。
- 索引病例因重复阴性IgG特异性EIA恢复肝素后出现复发性血小板减少和近致命性心脏骤停,提示肝素后HIT相关过敏样反应。
关键数值与推荐
- IgG特异性和多特异性PF4依赖性EIA对HIT诊断具有极高敏感性(≥99%)。
- 推荐使用IgG特异性EIA进行筛查,因其高敏感性伴随相对多特异性EIA较高的特异性。
- 8546例患者中约0.2%呈SRA+/EIA-血清学特征。
临床怎么用
- 临床怀疑HIT时应优先采用IgG特异性EIA进行筛查,并以其阳性作为SRA检测的前提。
- 对于EIA阴性但临床高度怀疑HIT者,需警惕假阴性可能,避免贸然恢复肝素。
- SRA阳性而EIA阴性结果应复核,排除分类错误或SRA假阳性。
局限性
- SRA+/EIA- HIT的频率估计基于单中心参考实验室6年数据,外推需谨慎。
- 复核的15例SRA+/EIA-病例均非真性HIT,但索引病例提示该情形可能存在,需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IgG-specific and polyspecific PF4-dependent enzyme-immunoassays (EIAs) have exceptionally high sensitivity (≥99%) for diagnosis of heparin-induced thrombocytopenia (HIT), a drug reaction caused by platelet-activating antibodies detectable by serotonin-release assay (SRA). The IgG-specific EIAs are recommended for screening, as their high sensitivity is accompanied by relatively high specificity vis-à-vis polyspecific EIAs. We investigated the frequency of SRA-positive/EIA-negative (SRA+/EIA-) HIT, prompted by referral to our reference HIT laboratory of serial blood samples from a patient ("index case") with false-negative IgG-specific EIAs. Despite initial clinical suspicion for HIT, repeat negative IgG-specific EIAs prompted heparin resumption, which triggered recurrent thrombocytopenia and near-fatal cardiac arrest, indicating likely post-heparin HIT-associated anaphylactoid reaction. Further investigations revealed a strong-positive SRA, whether performed with heparin alone, PF4 alone, or PF4/heparin, with inhibition by Fc receptor-blocking monoclonal antibody (indicating IgG-mediated platelet activation); however, five different IgG-specific immunoassays yielded primarily negative (or weak-positive) results. To investigate the frequency of SRA+/EIA- HIT, we reviewed the laboratory and clinical features of patients with this serological profile during a 6-year period in which our reference laboratory investigated for HIT using both SRA and IgG-specific EIA. Although ~0.2% of 8546 patients had an SRA+/EIA- profile, further review of 15 such cases indicated clerical/laboratory misclassification or false-positive SRA in all, with no SRA+/EIA- HIT case identified. We conclude that while SRA+/EIA- HIT is possible-as shown by our index case-this clinical picture is exceptionally uncommon. Moreover, the requirement for a positive EIA is a useful quality control maneuver that reduces risk of reporting a false-positive SRA result.
引用
- Warkentin TE, Smythe MA, Ali MA, et al. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? Am J Hematol. 2020. PMID: 33326124. doi:10.1002/ajh.26075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。